Whittier Trust Co. Buys 7,037 Shares of Intuitive Surgical, Inc. $ISRG

Whittier Trust Co. boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.8% during the 1st quarter, Holdings Channel reports. The institutional investor owned 111,103 shares of the medical equipment provider’s stock after buying an additional 7,037 shares during the quarter. Whittier Trust Co.’s holdings in Intuitive Surgical were worth $50,283,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in ISRG. Newbridge Financial Services Group Inc. increased its position in Intuitive Surgical by 300.0% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 33 shares during the period. Holos Integrated Wealth LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $25,000. Olistico Wealth LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $28,000. Laurel Wealth Advisors LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at $31,000. Finally, Turning Point Benefit Group Inc. boosted its stake in shares of Intuitive Surgical by 833.3% in the 4th quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock valued at $32,000 after purchasing an additional 50 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $426.01 on Monday. The firm has a market cap of $150.88 billion, a PE ratio of 51.64, a P/E/G ratio of 3.47 and a beta of 1.46. Intuitive Surgical, Inc. has a 12-month low of $396.68 and a 12-month high of $603.88. The company’s fifty day simple moving average is $427.27 and its 200 day simple moving average is $479.06.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The firm had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. During the same period in the previous year, the firm posted $1.81 earnings per share. The business’s revenue was up 23.0% compared to the same quarter last year. On average, equities analysts predict that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analysts and market commentators say Intuitive Surgical has a strong track record of beating expectations and could do so again in the upcoming quarter, helped by continued procedure growth and healthy demand for its robotic surgery systems. Why Intuitive Surgical (ISRG) Could Beat Earnings Estimates Again
• Positive Sentiment: Recent earnings-review coverage ranked Intuitive Surgical as one of the top performers in its surgical equipment and consumables peer group, reinforcing the company’s leadership position. Q1 Surgical Equipment & Consumables – Specialty Earnings Review: First Prize Goes to Intuitive Surgical (NASDAQ:ISRG)
• Positive Sentiment: Some investors appear to be buying ahead of the mid-July earnings call, citing first-quarter momentum, da Vinci 5 placements, and product-cycle improvements that could support another strong update. Intuitive Surgical Gains as Investors Appear to Position for Mid-July Earnings
• Neutral Sentiment: Wall Street remains divided, with preview pieces highlighting that strong forecasts are being offset by concerns about the stock’s recent weakness and valuation reset. Intuitive Surgical’s Quarterly Earnings Preview: What You Need to Know
• Neutral Sentiment: Broader investor flow data and insider selling activity show mixed signals, with some institutions adding shares while others reduced exposure, and executives continuing to sell stock. This is not a direct business catalyst, but it may contribute to cautious sentiment. Intuitive Surgical Gains as Investors Appear to Position for Mid-July Earnings
• Negative Sentiment: Recent coverage says Intuitive Surgical has fallen sharply from earlier levels and that some investors are concerned about margin pressure and a below-consensus outlook, which has helped keep the stock under pressure. Intuitive Surgical Is Down 28%, and Wall Street Is Piling On. Goldman Sachs Just Said Everyone Is Wrong — and History Is on Its Side.
• Negative Sentiment: Some recent commentary specifically notes the stock fell on a below-consensus forecast, suggesting expectations may have become harder to clear in the near term. Intuitive Surgical (ISRG) Fell on Below-Consensus Forecast

Insider Activity at Intuitive Surgical

In related news, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction that occurred on Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total transaction of $169,656.00. Following the transaction, the executive vice president directly owned 5,720 shares of the company’s stock, valued at approximately $2,426,080.80. This represents a 6.54% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 119 shares of the stock in a transaction that occurred on Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total value of $55,156.50. Following the completion of the transaction, the director owned 120 shares in the company, valued at approximately $55,620. The trade was a 49.79% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 7,169 shares of company stock valued at $3,059,135 in the last three months. Corporate insiders own 0.60% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently weighed in on ISRG. Weiss Ratings reissued a “hold (c)” rating on shares of Intuitive Surgical in a research note on Tuesday, May 19th. Deutsche Bank Aktiengesellschaft cut their price target on shares of Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating on the stock in a research report on Tuesday, June 2nd. JPMorgan Chase & Co. lowered their price objective on Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Truist Financial dropped their price objective on Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating on the stock in a research note on Wednesday, April 15th. Finally, TD Cowen cut their target price on Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Nineteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $573.42.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.